Women's Health Policy

ABORTION IN THE U.S.

Variability in Rebimbursement Rates for State-funded Abortion Services for Medicaid Enrollees: A 2026 Update

This analysis reveals that while more states have begun using their own funds to cover abortion services for Medicaid enrollees since the U.S. Supreme Court’s Dobbs decision, only a handful have significantly increased reimbursement rates for providers, potentially undermining access to care for low-income patients. After examining physician fee schedules for abortions provided to Medicaid enrollees since 2024, KFF finds that reimbursement rates vary dramatically across states, and that most states don't substantially increase payment rates for later-pregnancy procedures, despite their higher costs and complexity.

CONTRACEPTIve care IN THE U.S.

An Update on Medicaid, Title X and Planned Parenthood

This brief provides an update on Planned Parenthood clinic closures and participation in the Title X program amid substantial policy changes resulting in funding reductions. These changes include the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.

SELECTED RESOURCES

Over-the-Counter Oral Contraceptive Pills

In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.

featured

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Women’s Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials
  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.
  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.
  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.
  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Stay informed.

Stay informed.

Filter

641-650 of 875 results

  • Key Facts: Women and HIV/AIDS in the United States

    Report

    Key Facts: Women and HIV/AIDS Key Facts: Women and HIV/AIDS provides comprehensive data on the impact of HIV/AIDS epidemic on women in the United States. Based on the most recent data and research on the epidemiology of HIV/AIDS among women, the report includes an overview of the epidemic profile, a profile of women living with HIV/AIDS, data on access to and use of health services, and women’s perceptions of HIV/AIDS. Report (.pdf)

  • National Survey Results on Public Knowledge/Opinions and OB/GYN Practice/Attitudes on Emergency Contraceptives (“Morning-After Pills”) – Policy Brief

    Issue Brief

    EMERGENCY CONTRACEPTION: The Answer to America's Unplanned Pregnancy Problem? March, 1995 OVERVIEW For approximately 20 years, emergency contraceptive pills (ECPs), high-dose oral contraceptivesalso referred to as "morning-after pills," have been known to prevent pregnancy after unprotectedsex and available in the United States. Findings from a new Kaiser Family Foundation/LouisHarris and Associates, Inc. national public knowledge and opinion survey, however, indicate thatmost American women are uninformed or misinformed about the contraceptive alternative andfew have ever used…

  • Sexual Activity on Daytime Soap Operas: A Content Analysis of Five Weeks of Television Programming

    Report

    This study, conducted for the Kaiser Family Foundation by Katharine E. Heintz-Knowles, Ph.D., University of Washington, presents a "snapshot" of the sexual content on soap operas today. Katharine Heintz-Knowles examined 97 hours of programming from theten nationally televised soap operas between May 27 and June 28, 1996. The study was presented on September 7, 1996 to producers and writers of soap operas and network executives at SOAP SUMMIT II, a day-long seminar produced by Population…

  • State Medicaid Coverage of Perinatal Services: Summary of State Survey Findings

    Issue Brief

    The report examines state Medicaid program policies regarding coverage of pregnancy-related services. It details state-level Medicaid eligibility and enrollment policies for pregnant women, as well as scope of coverage for prenatal and screening services, delivery and post-partum care, educational classes and support services.

  • The U.S. Government’s Efforts to Address Global Maternal, Newborn, and Child Health: The Global Health Initiative and Beyond

    Other Post

    This report examines the U.S. role in improving global maternal, newborn, and child health, including the heightened focus placed on these issues by the Administration’s Global Health Initiative. It provides an overview of international efforts and a detailed look at the U.S. government’s response to date, reviews U.S. funding trends for maternal and child health, U.S. agencies’ related activities, the contribution of key U.S. global health efforts, and U.S. participation in international multilateral efforts. It…

  • Measuring the Effects of Sexual Content in the Media: A Report to the Kaiser Family Foundation

    Report

    Measuring the Effects of Sexual Content in the Media: A Report to the Kaiser Family Foundation This report provides a history of the research on sexual content in the media, an overview of the methods available for studying the effects of media, a discussion of some of the difficulties in doing research on this topic, and specific recommendations for future research on the effects on young viewers of sexual content in the media. This Report…

  • Will 1999 Be The Year For Mifepristone (RU-486) And, An Update on Women’s Other Options for Very Early Abortion

    Fact Sheet

    While there has been much attention to the few abortions that occur late in pregnancy, there has been little focus on what options are available during the early weeks, even days, of pregnancy, when most women seek abortions. The drugs mifepristone (also known as RU-486) and misoprostol have been available in France, England, and Sweden for much of the last decade as an earlier medical alternative to surgical abortion. Since becoming available, an estimated one-half…

  • Will 1999 Be The Year For Mifepristone (Ru-486)? And, An Update on Women’s Other Options for Very Early Abortion

    Other Post

    National Survey of Women's Health Care Providers on Medical Abortion September 16, 1998 One in Two Ob/Gyns Say They are Likely to Offer Mifepristone (RU-486) If Approved by FDA, And Almost Half Who Do Not Now Provide Abortions Say They Would Provide the Medical Alternative Many Family Practice Physicians, Nurse Practitioners and Physician AssistantsAlso Report Interest Menlo Park, CA - In the coming year, the Food and Drug Administration (FDA) is expected to complete its…